Demand for transcatheter heart valve replacement will increase through 2036, with balloon-expandable transcatheter aortic valves at 51.3% of the product segment in 2026, driven by increasing clinical adoption and expanding procedural volume. The market was valued at USD 8.18 billion in 2025 and is expected to be worth USD 37.69 billion by 2036.